RNA/DNA Qualification in LNPs with New Scatter-Free Absorption
No dyes, no dispersions, answers in seconds
May 7th 5pm CET | 11am EST
Intact LNP payload quantification using traditional methods is laborious, complex and time consuming. In this webinar, leading experts from 4basebio and Merck KGaA will discuss how Marama Labs’ new CloudSpec instrument enables faster formulation development by using Scatter-Free Absorption (SFA) for rapid payload quantification of intact particles – no sample dispersion or fluorescent dyes required.
Key Highlights:
- Introduction to Scatter-Free Absorption (SFA) technology – a new way to quantify payloads in intact LNPs in 2 minutes analysis time per sample
- Case studies and data demonstrating quantification of RNA and antibodies in LNP formulations
- Discussion on how SFA compares with methods such as the RiboGreen assay in terms of ease of use and precision of answers
- Introduction to Marama Labs’ CloudSpec instrument and how it translates into faster development times in nanomedicine development
- Q&A session where participants can interact with industry experts, gaining deeper insights into the practical applications and potential of SFA
Why Attend?
- Gain a thorough understanding of the latest technological advancements in LNP quantification and how it can speed up your workflows in LNP development
- Hear first-hand the practical benefits and implementation of CloudSpec from industry leaders
Join us for an informative session that will provide actionable improvements in your LNP formulation development and manufacturing. Register now to secure your spot!
Webinar Leaders
Speaker
Emily Young
Head Of Non-Viral Delivery
Speaker
Johanna Simon
Head of Formulation Discovery &
Analytical Characterisation
Who are Hanson Wade Intelligence?
Outsource your competitive intelligence to Hanson Wade Intelligence and have our analysts support your market landscaping and competitive benchmarking.
Hanson Wade Intelligence are modality experts with multi-project experience in preclinical and clinical evaluation of ADCs, Cell and Gene Therapy, RNA, Protein Degraders and much more. With strong primary and secondary research skills, Hanson Wade Intelligence is ideally positioned to be your CI partner.
